Latest & greatest articles for adverse events

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adverse events or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adverse events and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for adverse events

41. The quality of CONSORT adverse events reporting in phase III randomized controlled trials of breast and colorectal cancers: a systematic review

The quality of CONSORT adverse events reporting in phase III randomized controlled trials of breast and colorectal cancers: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

42. Adverse events following spinal cord injury: spectrum, relation to clinical outcome, prevention, and management methods

Adverse events following spinal cord injury: spectrum, relation to clinical outcome, prevention, and management methods Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

43. Adverse events associated with treatment of tripterygium glycosides: a systematic review and meta-analysis

Adverse events associated with treatment of tripterygium glycosides: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

44. Systemic adverse events with intravitreal anti-vascular endothelial growth factor therapies in adults with ocular diseases: a systematic review and meta-analysis of clinical trials

Systemic adverse events with intravitreal anti-vascular endothelial growth factor therapies in adults with ocular diseases: a systematic review and meta-analysis of clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

45. Risk of adverse events in patients with low on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis

Risk of adverse events in patients with low on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

46. Effects of perioperative hypotension avoidance strategies on reducing major adverse cardiac events for patients undergoing major non-cardiac surgery

Effects of perioperative hypotension avoidance strategies on reducing major adverse cardiac events for patients undergoing major non-cardiac surgery Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

47. Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: a Bayesian network meta-analysis of phase III randomized controlled trials

Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: a Bayesian network meta-analysis of phase III randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

48. Clinical risk prediction scores and high-sensitivity cardiac troponin assays for the prediction of major adverse cardiac events in adult emergency department patients with chest pain: a systematic review and meta-analysis

Clinical risk prediction scores and high-sensitivity cardiac troponin assays for the prediction of major adverse cardiac events in adult emergency department patients with chest pain: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

49. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. Full Text available with Trip Pro

Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. Higher baseline high-sensitivity C-reactive protein (hsCRP) levels after an acute coronary syndrome (ACS) are associated with adverse cardiovascular outcomes. The usefulness of serial hsCRP measurements for risk stratifying patients after ACS is not well characterized.To assess whether longitudinal increases in hsCRP (...) measurements during the 16 weeks after ACS are independently associated with a greater risk of a major adverse cardiac event (MACE), all-cause death, and cardiovascular death.Secondary analysis of the double-blind, multicenter, randomized clinical Vascular Inflammation Suppression to Treat Acute Coronary Syndromes for 16 Weeks (VISTA-16) trial conducted between June 1, 2010, and March 7, 2012 (study termination on March 9, 2012), which included 5145 patients from 362 academic and community hospitals

2019 JAMA cardiology Controlled trial quality: predicted high

50. Adverse events related to coloured dye injections used in sentinel lymph node mapping - a systematic review

Adverse events related to coloured dye injections used in sentinel lymph node mapping - a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

51. Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized control trials

Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized control trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

52. Predictors of medication related adverse events in wards inpatients

Predictors of medication related adverse events in wards inpatients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2019 PROSPERO

53. Psychiatric adverse events associated with pregabalin: systematic review and meta-analysis

Psychiatric adverse events associated with pregabalin: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

54. The effect of preoperative psychological aspects on surgical outcomes and adverse events in oncological patients

The effect of preoperative psychological aspects on surgical outcomes and adverse events in oncological patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

55. Effect of nighttime surgery on mortality and adverse events: a systematic review and meta-analysis

Effect of nighttime surgery on mortality and adverse events: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

56. Statins reduce major adverse limb events and mortality in patients with peripheral artery disease. A systematic review and meta-analysis

Statins reduce major adverse limb events and mortality in patients with peripheral artery disease. A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

57. Reporting of adverse events in randomized controlled trials of therapeutic exercise for knee osteoarthritis: a systematic review

Reporting of adverse events in randomized controlled trials of therapeutic exercise for knee osteoarthritis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

58. Adverse events in patients receiving placebo in phase III trials of biologics for psoriasis: a systematic review and meta-analysis

Adverse events in patients receiving placebo in phase III trials of biologics for psoriasis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

59. Adverse cardiac events of PD-1 and PD-L1 inhibitors in the treatment of cancer: a network meta-analysis

Adverse cardiac events of PD-1 and PD-L1 inhibitors in the treatment of cancer: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

60. Cardiac adverse events of PD-1 and PD-L1 inhibitors in cancer: a systematic review and network meta-analysis

Cardiac adverse events of PD-1 and PD-L1 inhibitors in cancer: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO